Following up on previous studies demonstrating the pro-amyloidogenic effects of Il10 and Il4 [18, 19], here we tested if a decoy receptor strategy against these cytokines would mitigate AD-typical amyloid and tau pathology. This evidence concerns the gene IL10 and Alzheimer disease.